$USNA
USANA HEALTH SCIENCES INC

2024 Q4 Form 10-Q Financial Statement

#000089626424000222 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $200.2M
YoY Change -15.94%
Cost Of Revenue $39.26M
YoY Change -9.39%
Gross Profit $161.0M
YoY Change -17.4%
Gross Profit Margin 80.39%
Selling, General & Admin $145.4M
YoY Change -14.73%
% of Gross Profit 90.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.569M
YoY Change 10.84%
% of Gross Profit 2.22%
Operating Expenses $145.4M
YoY Change -14.73%
Operating Profit $15.60M
YoY Change -36.06%
Interest Expense $3.093M
YoY Change 7093.02%
% of Operating Profit 19.83%
Other Income/Expense, Net -$86.00K
YoY Change -103.57%
Pretax Income $18.61M
YoY Change -30.59%
Income Tax $8.001M
% Of Pretax Income 43.0%
Net Earnings $10.61M
YoY Change -38.66%
Net Earnings / Revenue 5.3%
Basic Earnings Per Share $0.56
Diluted Earnings Per Share $0.56
COMMON SHARES
Basic Shares Outstanding 19.06M shares 19.05M shares
Diluted Shares Outstanding 19.08M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $364.9M
YoY Change 21.56%
Cash & Equivalents $364.9M
Short-Term Investments
Other Short-Term Assets $22.32M
YoY Change -12.48%
Inventory $63.98M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $451.2M
YoY Change 16.39%
LONG-TERM ASSETS
Property, Plant & Equipment $98.03M
YoY Change 2.4%
Goodwill $17.20M
YoY Change 2.0%
Intangibles $29.24M
YoY Change -2.53%
Long-Term Investments $20.00M
YoY Change 0.0%
Other Assets $75.65M
YoY Change 4.43%
Total Long-Term Assets $220.1M
YoY Change 2.36%
TOTAL ASSETS
Total Short-Term Assets $451.2M
Total Long-Term Assets $220.1M
Total Assets $671.3M
YoY Change 11.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.041M
YoY Change -24.07%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $114.8M
YoY Change 0.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $18.72M
YoY Change 22.96%
Total Long-Term Liabilities $18.72M
YoY Change 22.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.8M
Total Long-Term Liabilities $18.72M
Total Liabilities $138.2M
YoY Change 3.26%
SHAREHOLDERS EQUITY
Retained Earnings $474.5M
YoY Change 11.04%
Common Stock $72.30M
YoY Change 20.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $533.1M
YoY Change
Total Liabilities & Shareholders Equity $671.3M
YoY Change 11.39%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $10.61M
YoY Change -38.66%
Depreciation, Depletion And Amortization $3.569M
YoY Change 10.84%
Cash From Operating Activities $29.53M
YoY Change 209.22%
INVESTING ACTIVITIES
Capital Expenditures $2.399M
YoY Change -33.53%
Acquisitions
YoY Change
Other Investing Activities $61.00K
YoY Change -98.39%
Cash From Investing Activities -$2.338M
YoY Change -1406.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -78.00K
YoY Change 41.82%
NET CHANGE
Cash From Operating Activities 29.53M
Cash From Investing Activities -2.338M
Cash From Financing Activities -78.00K
Net Change In Cash 27.12M
YoY Change 180.29%
FREE CASH FLOW
Cash From Operating Activities $29.53M
Capital Expenditures $2.399M
Free Cash Flow $27.14M
YoY Change 356.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-28
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
USNA
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29919000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16823000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13284000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58828000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54892000 usd
CY2024Q3 us-gaap Assets
Assets
671308000 usd
CY2023Q4 us-gaap Assets
Assets
632757000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7041000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-86000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
234000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3007000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2924000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18608000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
10607000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
61454000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
98033000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39257000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42529000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
160964000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
170836000 usd
CY2024Q3 usna Associate Incentives
AssociateIncentives
84068000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
145363000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
153229000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15601000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17607000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3142000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2733000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20531000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8001000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
11347000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
11347000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
7654000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-1933000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17416000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9599000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
533087000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22225000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19848000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3709000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4707000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
38050000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
36899000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
63984000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
61454000 usd
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
2938000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3128000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-621000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
497202000 usd
us-gaap Net Income Loss
NetIncomeLoss
37576000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10945000 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0500306
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
213365000 usd
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Local Phone Number
LocalPhoneNumber
954-7100
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19059572 shares
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25872000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
451191000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
417746000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
99814000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
17196000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
17102000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29237000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10070000 usd
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
786000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
107738000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4727000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4552000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18715000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12158000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19056000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19056000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
19000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
19000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
72277000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
65661000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
474490000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
445217000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13699000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13695000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
533087000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
497202000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
671308000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
632757000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
200221000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
640890000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
699927000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
122659000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
134374000 usd
us-gaap Gross Profit
GrossProfit
518231000 usd
us-gaap Gross Profit
GrossProfit
565553000 usd
CY2023Q3 usna Associate Incentives
AssociateIncentives
89926000 usd
usna Associate Incentives
AssociateIncentives
270197000 usd
usna Associate Incentives
AssociateIncentives
298376000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61295000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
189920000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28820000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
10607000 usd
us-gaap Net Income Loss
NetIncomeLoss
37576000 usd
us-gaap Net Income Loss
NetIncomeLoss
47022000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.44
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
706000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-8236000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
845000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-185000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
710000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-799000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6809000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1748000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7437000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37572000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39585000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
434472000 usd
us-gaap Net Income Loss
NetIncomeLoss
47022000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7437000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10952000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
470394000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000896264
dei Entity Registrant Name
EntityRegistrantName
USANA HEALTH SCIENCES, INC.
dei Entity Address Address Line1
EntityAddressAddressLine1
3838 West Parkway Blvd.
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84120
dei City Area Code
CityAreaCode
801
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
364889000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
330420000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
63984000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22318000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
107989000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
114779000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
118845000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19130000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19130000 shares
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63303000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
198325000 usd
us-gaap Operating Expenses
OperatingExpenses
460117000 usd
us-gaap Operating Expenses
OperatingExpenses
496701000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
58114000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
68852000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
8581000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6732000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
49000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
43000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
152000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
117000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
375000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7808000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6990000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65922000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
75842000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9184000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28346000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.43
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19078000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19245000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19108000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19283000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19083000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19372000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19181000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19376000 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
10607000 usd
us-gaap Net Income Loss
NetIncomeLoss
37576000 usd
us-gaap Net Income Loss
NetIncomeLoss
47022000 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11657000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2958000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9483000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3149000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
468824000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
11347000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1748000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3670000 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11657000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
42000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
470394000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
512208000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6809000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3542000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
79000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
533087000 usd
us-gaap Net Income Loss
NetIncomeLoss
37576000 usd
us-gaap Net Income Loss
NetIncomeLoss
47022000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10540000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9790000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5805000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5734000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10945000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10952000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4047000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4218000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1889000 usd
us-gaap Inventory Write Down
InventoryWriteDown
3107000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3794000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-296000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1247000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5116000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3044000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2357000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1911000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-30836000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
55207000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44618000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
1125000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
3775000 usd
us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
870000 usd
us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
1271000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
64000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8271000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7170000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7952000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4653000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9444000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11599000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
689000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
750000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1473000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
750000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3149000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2958000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
338000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13377000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14895000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
617000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6567000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34495000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18503000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
333246000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
291320000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
367741000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
309823000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
364889000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
307081000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2852000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2742000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
367741000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
309823000 usd
us-gaap Interest Paid Net
InterestPaidNet
73000 usd
us-gaap Interest Paid Net
InterestPaidNet
5000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
33265000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
35958000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
7000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
1164000 usd
usna Right Of Use Assets Obtained In Exchange For Lease Obligations
RightOfUseAssetsObtainedInExchangeForLeaseObligations
9915000 usd
usna Right Of Use Assets Obtained In Exchange For Lease Obligations
RightOfUseAssetsObtainedInExchangeForLeaseObligations
4963000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
101000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1384000 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
39000 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
58000 usd
usna Number Of Geographic Regions
NumberOfGeographicRegions
2 region
usna Number Of Sub Geographical Regions
NumberOfSubGeographicalRegions
3 region
us-gaap Use Of Estimates
UseOfEstimates
The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. In the opinion of the Company’s management, the accompanying interim condensed consolidated financial information contains all adjustments, consisting only of normal recurring adjustments, that are necessary to state fairly the Company’s financial position as of September 28, 2024, and results of operations and cash flows for the three and nine months ended September 28, 2024 and September 30, 2023.
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications relate to the disaggregation of inventory write-downs from changes in inventories within operating activities of the Condensed Consolidated Statements of Cash Flows.</span></div>
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2024Q3 us-gaap Other Income
OtherIncome
512000 usd
CY2023Q3 us-gaap Other Income
OtherIncome
715000 usd
us-gaap Other Income
OtherIncome
1874000 usd
us-gaap Other Income
OtherIncome
2196000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13910000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20875000 usd
usna Increase Due To Deferral Of Revenue At End Of Period
IncreaseDueToDeferralOfRevenueAtEndOfPeriod
11188000 usd
CY2023 usna Increase Due To Deferral Of Revenue At End Of Period
IncreaseDueToDeferralOfRevenueAtEndOfPeriod
13910000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
13009000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
20875000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12089000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13910000 usd
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
786000 usd
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
255000 usd
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
2504000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10607000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11347000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
37576000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
47022000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19078000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19245000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19108000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19283000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
127000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
73000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
93000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19083000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19372000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19181000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19376000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.44
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.43
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
628000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
315000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
570000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
322000 shares
CY2024Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
180000 shares
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11657000 usd
CY2023Q3 usna Stock Repurchased Excise Tax Payable
StockRepurchasedExciseTaxPayable
58000 usd
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
194000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
180000 shares
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9483000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11657000 usd
CY2024Q3 usna Stock Repurchased Excise Tax Payable
StockRepurchasedExciseTaxPayable
39000 usd
CY2023Q3 usna Stock Repurchased Excise Tax Payable
StockRepurchasedExciseTaxPayable
58000 usd
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
61703000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
200221000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
213365000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
640890000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
699927000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
200221000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
213365000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
640890000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
699927000 usd
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000896264-24-000222-index-headers.html Edgar Link pending
0000896264-24-000222-index.html Edgar Link pending
0000896264-24-000222.txt Edgar Link pending
0000896264-24-000222-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thirdamendmenttosecondamen.htm Edgar Link pending
usna-20240928.htm Edgar Link pending
usna-20240928.xsd Edgar Link pending
usna-20240928xex311.htm Edgar Link pending
usna-20240928xex312.htm Edgar Link pending
usna-20240928xex321.htm Edgar Link pending
usna-20240928xex322.htm Edgar Link pending
usna-20240928_cal.xml Edgar Link unprocessable
usna-20240928_def.xml Edgar Link unprocessable
usna-20240928_lab.xml Edgar Link unprocessable
usna-20240928_pre.xml Edgar Link unprocessable
usna-20240928_htm.xml Edgar Link completed